Cargando…

Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies

Detalles Bibliográficos
Autores principales: Sanchez, David, Radigan, Lin, Cunningham-Rundles, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895881/
http://dx.doi.org/10.1016/j.jaci.2022.12.610
_version_ 1784881942171222016
author Sanchez, David
Radigan, Lin
Cunningham-Rundles, Charlotte
author_facet Sanchez, David
Radigan, Lin
Cunningham-Rundles, Charlotte
author_sort Sanchez, David
collection PubMed
description
format Online
Article
Text
id pubmed-9895881
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98958812023-02-06 Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies Sanchez, David Radigan, Lin Cunningham-Rundles, Charlotte J Allergy Clin Immunol Article Published by Mosby, Inc. 2023-02 2023-02-03 /pmc/articles/PMC9895881/ http://dx.doi.org/10.1016/j.jaci.2022.12.610 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sanchez, David
Radigan, Lin
Cunningham-Rundles, Charlotte
Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title_full Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title_fullStr Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title_full_unstemmed Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title_short Assessing SARS-CoV-2 Antigen Specific T-cell Responses After mRNA Vaccination and/or Omicron Variant COVID-19 Infection in Patients with Primary Humoral Immunodeficiencies
title_sort assessing sars-cov-2 antigen specific t-cell responses after mrna vaccination and/or omicron variant covid-19 infection in patients with primary humoral immunodeficiencies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895881/
http://dx.doi.org/10.1016/j.jaci.2022.12.610
work_keys_str_mv AT sanchezdavid assessingsarscov2antigenspecifictcellresponsesaftermrnavaccinationandoromicronvariantcovid19infectioninpatientswithprimaryhumoralimmunodeficiencies
AT radiganlin assessingsarscov2antigenspecifictcellresponsesaftermrnavaccinationandoromicronvariantcovid19infectioninpatientswithprimaryhumoralimmunodeficiencies
AT cunninghamrundlescharlotte assessingsarscov2antigenspecifictcellresponsesaftermrnavaccinationandoromicronvariantcovid19infectioninpatientswithprimaryhumoralimmunodeficiencies